BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akil O. Dual and triple AAV delivery of large therapeutic gene sequences into the inner ear. Hearing Research 2020;394:107912. [DOI: 10.1016/j.heares.2020.107912] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Thorpe RK, Walls WD, Corrigan R, Schaefer A, Wang K, Huygen P, Casavant TL, Smith RJH. AudioGene: refining the natural history of KCNQ4, GSDME, WFS1, and COCH-associated hearing loss. Hum Genet 2022. [PMID: 35038006 DOI: 10.1007/s00439-021-02424-7] [Reference Citation Analysis]
2 Whatley M, Francis A, Ng ZY, Khoh XE, Atlas MD, Dilley RJ, Wong EYM. Usher Syndrome: Genetics and Molecular Links of Hearing Loss and Directions for Therapy. Front Genet 2020;11:565216. [PMID: 33193648 DOI: 10.3389/fgene.2020.565216] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yoshimura H, Nishio SY, Usami SI. Milestones toward cochlear gene therapy for patients with hereditary hearing loss. Laryngoscope Investig Otolaryngol 2021;6:958-67. [PMID: 34693000 DOI: 10.1002/lio2.633] [Reference Citation Analysis]
4 Lu L, Yu X, Cai Y, Sun M, Yang H. Application of CRISPR/Cas9 in Alzheimer's Disease. Front Neurosci 2021;15:803894. [PMID: 34992519 DOI: 10.3389/fnins.2021.803894] [Reference Citation Analysis]
5 Macdonald J, Marx J, Büning H. Capsid-Engineering for Central Nervous System-Directed Gene Therapy with Adeno-Associated Virus Vectors. Hum Gene Ther 2021;32:1096-119. [PMID: 34662226 DOI: 10.1089/hum.2021.169] [Reference Citation Analysis]
6 Fakhiri J, Landegger LD, Grimm D. Breaking the sound barrier: Towards next-generation AAV vectors for gene therapy of hearing disorders. Hear Res 2020;:108092. [PMID: 33268240 DOI: 10.1016/j.heares.2020.108092] [Reference Citation Analysis]
7 Wu J, Solanes P, Nist-Lund C, Spataro S, Shubina-Oleinik O, Marcovich I, Goldberg H, Schneider BL, Holt JR. Single and Dual Vector Gene Therapy with AAV9-PHP.B Rescues Hearing in Tmc1 Mutant Mice. Mol Ther 2021;29:973-88. [PMID: 33212302 DOI: 10.1016/j.ymthe.2020.11.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Botto C, Dalkara D, El-Amraoui A. Progress in Gene Editing Tools and Their Potential for Correcting Mutations Underlying Hearing and Vision Loss. Front Genome Ed 2021;3:737632. [PMID: 34778871 DOI: 10.3389/fgeed.2021.737632] [Reference Citation Analysis]
9 Isherwood B, Gonçalves AC, Cousins R, Holme R. The global hearing therapeutic pipeline: 2021. Drug Discov Today 2021:S1359-6446(21)00488-8. [PMID: 34775104 DOI: 10.1016/j.drudis.2021.11.009] [Reference Citation Analysis]
10 Dinculescu A, Link BA, Saperstein DA. Retinal Gene Therapy for Usher Syndrome: Current Developments, Challenges, and Perspectives. Int Ophthalmol Clin 2021;61:109-24. [PMID: 34584048 DOI: 10.1097/IIO.0000000000000378] [Reference Citation Analysis]